Re:FDA clears blood test to aid evaluation for Alzheimer's d...
by computerdork on Monday August 24, 2026 @05:40PM
(#49426218)
Hi there. Actually, Leqembi is a 1st gen Alzheimer’s drugs and targets amyloid plaques. But, like other responses, amyloids doesn’t seem to be hugely responsible for Alzheimers, which is why targeting things like tau proteins is being explored.
[ Parent
| on HN ]
There are no comments on this comment yet.